» Articles » PMID: 28571019

High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration

Overview
Journal Blood Purif
Specialty Hematology
Date 2017 Jun 2
PMID 28571019
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hemodiafiltration on-line (on-line HDF) is a more efficient treatment than low-flux hemodialysis (HD). Unfortunately, it cannot be proposed to all patients. The aim of this study was to evaluate the safety, efficiency, and mechanisms of removal of toxins with high-flux HD vs. low-flux HD and on-line HDF. Randomized cross-over study designed to evaluate efficiency and tolerability of high-flux HD vs. low-flux HD in aged patients; to compare by means of biochemical and proteomic analyses the efficiency and mechanisms of removal of toxins with high-flux HD vs. on-line HDF. The removal of small toxins was similar with high-flux and low-flux HD. β2-microglobulin was removed only with high-flux HD, which had an excellent tolerability. The efficiency of high-flux HD was similar to on-line HDF. Proteomic analysis demonstrated that only high-flux membranes remove and adsorb small proteins. High-flux HD may be an efficient alternative to on-line HDF.

Citing Articles

Real-world effectiveness of hemodialysis modalities: a retrospective cohort study.

Zhang Y, Winter A, Ferreras B, Carioni P, Arkossy O, Anger M BMC Nephrol. 2025; 26(1):9.

PMID: 39773397 PMC: 11706171. DOI: 10.1186/s12882-024-03934-y.


Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.

Abe M, Kikuchi K, Wada A, Nakai S, Kanda E, Hanafusa N Sci Rep. 2024; 14(1):10272.

PMID: 38704419 PMC: 11069571. DOI: 10.1038/s41598-024-60831-y.


Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.

Abe M, Masakane I, Wada A, Nakai S, Nitta K, Nakamoto H Clin Kidney J. 2022; 15(3):473-483.

PMID: 35211304 PMC: 8862063. DOI: 10.1093/ckj/sfab177.


Establishing Cell Models to Understand Cellular Toxicity: Lessons Learned from an Unconventional Cell Type.

Vollmer T, Stegmayr B Toxins (Basel). 2022; 14(1).

PMID: 35051031 PMC: 8779380. DOI: 10.3390/toxins14010054.


Dialyzer Classification and Mortality in Hemodialysis Patients: A 3-Year Nationwide Cohort Study.

Abe M, Masakane I, Wada A, Nakai S, Nitta K, Nakamoto H Front Med (Lausanne). 2021; 8:740461.

PMID: 34513892 PMC: 8429602. DOI: 10.3389/fmed.2021.740461.